{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:43:09Z","timestamp":1785300189920,"version":"3.55.0"},"reference-count":128,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Granulomas have been defined as inflammatory infiltrates formed by recruitment of macrophages and T cells. The three-dimensional spherical structure typically consists of a central core of tissue resident macrophages which may merge into multinucleated giant cells surrounded by T cells at the periphery. Granulomas may be triggered by infectious and non-infectious antigens. Cutaneous and visceral granulomas are common in inborn errors of immunity (IEI), particularly among patients with chronic granulomatous disease (CGD), combined immunodeficiency (CID), and common variable immunodeficiency (CVID). The estimated prevalence of granulomas in IEI ranges from 1%\u20134%. Infectious agents causing granulomas such Mycobacteria and Coccidioides presenting atypically may be \u2018sentinel\u2019 presentations for possible underlying immunodeficiency. Deep sequencing of granulomas in IEI has revealed non-classical antigens such as wild-type and RA27\/3 vaccine-strain Rubella virus. Granulomas in IEI are associated with significant morbidity and mortality. The heterogeneity of granuloma presentation in IEI presents challenges for mechanistic approaches to treatment. In this review, we discuss the main infectious triggers for granulomas in IEI and the major forms of IEI presenting with \u2018idiopathic\u2019 non-infectious granulomas. We also discuss models to study granulomatous inflammation and the impact of deep-sequencing technology while searching for infectious triggers of granulomatous inflammation. We summarize the overarching goals of management and highlight the therapeutic options reported for specific granuloma presentations in IEI.<\/jats:p>","DOI":"10.3389\/fped.2023.1110115","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T07:28:12Z","timestamp":1676878092000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Granulomatous inflammation in inborn errors of immunity"],"prefix":"10.3389","volume":"11","author":[{"given":"Keith A.","family":"Sacco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gazzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavia M.","family":"Delmonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1146\/annurev-immunol-032712-100022","article-title":"The formation and function of granulomas","volume":"36","author":"Pagan","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.cell.2021.02.046","article-title":"A non-canonical type 2 immune response coordinates tuberculous granuloma formation and epithelialization","volume":"184","author":"Cronan","year":"2021","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nri3211","article-title":"Revisiting the role of the granuloma in tuberculosis","volume":"12","author":"Ramakrishnan","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/MOH.0000000000000301","article-title":"Mechanism of granuloma formation in sarcoidosis","volume":"24","author":"Sakthivel","year":"2017","journal-title":"Curr Opin Hematol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"797749","DOI":"10.3389\/fcimb.2022.797749","article-title":"Offense and defense in granulomatous inflammation disease","volume":"12","author":"Wang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01352-z","article-title":"The 2022 update of IUIS phenotypical classification for human inborn errors of immunity","volume":"42","author":"Bousfiha","year":"2022","journal-title":"J Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.159491","article-title":"Immunogenetics associated with severe coccidioidomycosis","volume":"7","author":"Hsu","year":"2022","journal-title":"JCI Insight"},{"key":"B9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jamadermatol.2022.0055","article-title":"Rubella virus-associated granulomas in immunocompetent adults-possible implications","volume":"158","author":"Notarangelo","year":"2022","journal-title":"JAMA Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/ACI.0000000000000694","article-title":"Rubella virus-associated chronic inflammation in primary immunodeficiency diseases","volume":"20","author":"Perelygina","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s10875-018-0534-7","article-title":"Prevalence of granulomas in patients with primary immunodeficiency disorders, United States: data from national health care claims and the US immunodeficiency network registry","volume":"38","author":"Leung","year":"2018","journal-title":"J Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s10875-022-01342-1","article-title":"High inborn errors of immunity risk in patients with granuloma","volume":"42","author":"Suleyman","year":"2022","journal-title":"J Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.jaci.2011.02.039","article-title":"Genome-wide association identifies diverse causes of common variable immunodeficiency","volume":"127","author":"Orange","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3389\/fimmu.2018.00636","article-title":"Evaluating the genetics of common Variable immunodeficiency: monogenetic model and beyond","volume":"9","author":"de Valles-Ibanez","year":"2018","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"606389","DOI":"10.3389\/fimmu.2020.606389","article-title":"What works when treating granulomatous disease in genetically undefined CVID? A systematic review","volume":"11","author":"van Stigt","year":"2020","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"627423","DOI":"10.3389\/fimmu.2021.627423","article-title":"Granulomatous lymphocytic interstitial lung disease (GLILD) in common Variable immunodeficiency (CVID): a multicenter retrospective study of patients from Italian PID referral centers","volume":"12","author":"Cinetto","year":"2021","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1513\/AnnalsATS.201511-728OC","article-title":"Clinical predictors of a diagnosis of common Variable immunodeficiency-related granulomatous-lymphocytic interstitial lung disease","volume":"13","author":"Mannina","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s10875-022-01290-w","article-title":"Clinical and phenotypic characterization of common Variable immunodeficiency diagnosed in younger and older adults","volume":"42","author":"Fortier","year":"2022","journal-title":"J Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"622114","DOI":"10.3389\/fimmu.2020.622114","article-title":"B cell dysregulation in common Variable immunodeficiency interstitial lung disease","volume":"11","author":"Matson","year":"2020","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jaci.2021.06.008","article-title":"Convergence of cytokine dysregulation and antibody deficiency in common variable immunodeficiency with inflammatory complications","volume":"149","author":"Abyazi","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"606099","DOI":"10.3389\/fimmu.2021.606099","article-title":"Treatment strategies for GLILD in common Variable immunodeficiency: a systematic review","volume":"12","author":"Lamers","year":"2021","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies","volume":"137","author":"Orange","year":"2010","journal-title":"Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jaip.2017.01.021","article-title":"British Lung foundation\/United Kingdom primary immunodeficiency network consensus statement on the definition, diagnosis, and management of granulomatous-lymphocytic interstitial lung disease in common Variable immunodeficiency disorders","volume":"5","author":"Hurst","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B25","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jaci.2020.07.021","article-title":"Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency","volume":"147","author":"Verbsky","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/ijd.12765","article-title":"Cutaneous granulomas in the setting of primary immunodeficiency: a report of four cases and review of the literature","volume":"54","author":"Harp","year":"2015","journal-title":"Int J Dermatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s10875-018-0537-4","article-title":"RAG Deficiency: two genes, many diseases","volume":"38","author":"Delmonte","year":"2018","journal-title":"J Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1146\/annurev.immunol.18.1.495","article-title":"The RAG proteins and V(D)J recombination: complexes, ends, and transposition","volume":"18","author":"Fugmann","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41590-022-01271-6","article-title":"Partial RAG deficiency in humans induces dysregulated peripheral lymphocyte development and humoral tolerance defect with accumulation of T-bet(+) B cells","volume":"23","author":"Csomos","year":"2022","journal-title":"Nat Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1056\/NEJMoa073966","article-title":"An immunodeficiency disease with RAG mutations and granulomas","volume":"358","author":"Schuetz","year":"2008","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.clim.2010.01.013","article-title":"More than just SCID\u2013the phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2","volume":"135","author":"Niehues","year":"2010","journal-title":"Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1182\/blood-2010-02-267583","article-title":"Hypomorphic rag mutations can cause destructive midline granulomatous disease","volume":"116","author":"De Ravin","year":"2010","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.jaip.2019.02.038","article-title":"Outcomes and treatment strategies for autoimmunity and hyperinflammation in patients with RAG deficiency","volume":"7","author":"Farmer","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B34","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1182\/blood.2019000923","article-title":"Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency","volume":"135","author":"Delmonte","year":"2020","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10875-016-0326-x","article-title":"Unrelated hematopoietic cell transplantation in a patient with combined immunodeficiency with granulomatous disease and autoimmunity secondary to RAG deficiency","volume":"36","author":"John","year":"2016","journal-title":"J Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2018.08.002","volume":"197","author":"Esenboga","year":"2018","journal-title":"Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.jaci.2015.01.040","article-title":"PRKDC Mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity","volume":"135","author":"Mathieu","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s10875-019-0589-0","article-title":"Outcomes for nitazoxanide treatment in a case series of patients with primary immunodeficiencies and Rubella virus-associated granuloma","volume":"39","author":"Perelygina","year":"2019","journal-title":"J Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a002816","article-title":"Bloom syndrome: research and data priorities for the development of precision medicine as identified by some affected families","volume":"4","author":"Campbell","year":"2018","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1073\/pnas.090525897","article-title":"Nuclear structure in normal and bloom syndrome cells","volume":"97","author":"Yankiwski","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1111\/jdv.15568","article-title":"Cutaneous granulomas with primary immunodeficiency in children: a report of 17 new patients and a review of the literature","volume":"33","author":"Leclerc-Mercier","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jaad.2012.12.950","article-title":"Dermatologic manifestations of ataxia-telangiectasia syndrome","volume":"68","author":"Greenberger","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.3389\/fimmu.2018.02000","article-title":"Treatment of granulomas in patients with ataxia telangiectasia","volume":"9","author":"Woelke","year":"2018","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000330335","article-title":"Cutaneous granulomas in ataxia telangiectasia and other primary immunodeficiencies: reflection of inappropriate immune regulation?","volume":"223","author":"Chiam","year":"2011","journal-title":"Dermatology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"760","DOI":"10.5114\/ada.2020.100485","article-title":"Cutaneous and systemic granulomatosis in ataxia-telangiectasia: a clinico-pathological study","volume":"37","author":"Szczawinska-Poplonyk","year":"2020","journal-title":"Postepy Dermatol Alergol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.jaci.2016.06.030","article-title":"Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies","volume":"138","author":"Perelygina","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"796065","DOI":"10.3389\/fimmu.2021.796065","article-title":"Rubella virus infected macrophages and neutrophils define patterns of granulomatous inflammation in inborn and acquired errors of immunity","volume":"12","author":"Perelygina","year":"2021","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e375","DOI":"10.1111\/pde.13676","article-title":"Chronic granulomatous skin lesions leading to a diagnosis of TAP1 deficiency syndrome","volume":"35","author":"Law-Ping-Man","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1172\/JCI5687","article-title":"HLA Class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1","volume":"103","author":"de la Salle","year":"1999","journal-title":"J Clin Invest"},{"key":"B50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10875-022-01374-7","article-title":"Delayed diagnosis of chronic necrotizing granulomatous skin lesions due to TAP2 deficiency","volume":"43","author":"Darazam","year":"2022","journal-title":"J Clin Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1111\/pde.12151","article-title":"Transporter associated with antigen processing deficiency syndrome: case report of an adolescent with chronic perforated granulomatous skin lesions due to TAP2 mutation","volume":"30","author":"Konstantinou","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s00405-008-0610-3","article-title":"TAP Deficiency syndrome: chronic rhinosinusitis and conductive hearing loss","volume":"265","author":"Caversaccio","year":"2008","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"108801","DOI":"10.1016\/j.clim.2021.108801","article-title":"Stem cell transplantation as treatment for major histocompatibility class I deficiency","volume":"229","author":"Tsilifis","year":"2021","journal-title":"Clin Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s10875-013-9962-6","article-title":"Phenotypic variations of cartilage hair hypoplasia: granulomatous skin inflammation and severe T cell immunodeficiency as initial clinical presentation in otherwise well child with short stature","volume":"34","author":"McCann","year":"2014","journal-title":"J Clin Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ejmg.2013.04.004","article-title":"Foetal presentation of cartilage hair hypoplasia with extensive granulomatous inflammation","volume":"56","author":"Crahes","year":"2013","journal-title":"Eur J Med Genet"},{"key":"B56","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jaci.2011.05.024","article-title":"Granulomatous inflammation in cartilage-hair hypoplasia: risks and benefits of anti-TNF-alpha mAbs","volume":"128","author":"Moshous","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jaci.2021.05.007","article-title":"Rubella vaccine-induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity","volume":"149","author":"Gross","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1177\/10935266211022528","article-title":"Granulomatous lymphocytic interstitial lung disease in a Spectrum of pediatric primary immunodeficiencies","volume":"24","author":"Szczawinska-Poplonyk","year":"2021","journal-title":"Pediatr Dev Pathol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12016-020-08800-x","article-title":"Chronic granulomatous disease: a comprehensive review","volume":"61","author":"Yu","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.hoc.2012.11.002","article-title":"Chronic granulomatous disease","volume":"27","author":"Holland","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","article-title":"Residual NADPH oxidase and survival in chronic granulomatous disease","volume":"363","author":"Kuhns","year":"2010","journal-title":"N Engl J Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jaci.2014.04.014","article-title":"Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease","volume":"134","author":"Magnani","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/INF.0b013e31822835ba","article-title":"Hyperinflammatory pulmonary disease in chronic granulomatous disease","volume":"30","author":"Hill","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"B64","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/cid\/ciw837","article-title":"Chronic granulomatous disease in patients reaching adulthood: a nationwide study in France","volume":"64","author":"Dunogue","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B65","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1542\/peds.114.2.462","article-title":"Gastrointestinal involvement in chronic granulomatous disease","volume":"114","author":"Marciano","year":"2004","journal-title":"Pediatrics"},{"key":"B66","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0022-5347(17)61580-5","article-title":"Interstitial cystitis in chronic granulomatous disease","volume":"105","author":"Kontras","year":"1971","journal-title":"J Urol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/INF.0b013e318218181d","article-title":"Corticosteroids in the treatment of severe nocardia pneumonia in chronic granulomatous disease","volume":"30","author":"Freeman","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"B68","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1081-1206(10)60023-3","article-title":"Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature","volume":"97","author":"Yamazaki-Nakashimada","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"636","DOI":"10.4049\/jimmunol.172.1.636","article-title":"Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease","volume":"172","author":"Kobayashi","year":"2004","journal-title":"J Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/eji.200636651","article-title":"Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B","volume":"37","author":"Bylund","year":"2007","journal-title":"Eur J Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1189\/jlb.71.3.410","article-title":"Thioglycollate peritonitis in mice lacking C5, 5-lipoxygenase, or p47(phox): complement, leukotrienes, and reactive oxidants in acute inflammation","volume":"71","author":"Segal","year":"2002","journal-title":"J Leukoc Biol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.clim.2008.06.005","article-title":"ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease","volume":"129","author":"Brown","year":"2008","journal-title":"Clin Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4049\/jimmunol.174.1.411","article-title":"Inhibition of human neutrophil IL-8 production by hydrogen peroxide and dysregulation in chronic granulomatous disease","volume":"174","author":"Lekstrom-Himes","year":"2005","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e9631","DOI":"10.1371\/journal.pone.0009631","article-title":"NADPH Oxidase limits innate immune responses in the lungs in mice","volume":"5","author":"Segal","year":"2010","journal-title":"PLoS One"},{"key":"B75","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1073\/pnas.0914795107","article-title":"Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease","volume":"107","author":"van de Veerdonk","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1053\/j.gastro.2008.02.081","article-title":"Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease","volume":"134","author":"Feld","year":"2008","journal-title":"Gastroenterology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e13084","DOI":"10.1111\/sji.13084","article-title":"Differential diagnosis of primary immunodeficiency in patients with BCGitis and BCGosis: a single-centre study","volume":"94","author":"Soyak Aytekin","year":"2021","journal-title":"Scand J Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s12098-018-2624-1","article-title":"BCGosis in infants with severe combined ImmunoDeficiency (SCID)","volume":"85","author":"Chitamanni","year":"2018","journal-title":"Indian J Pediatr"},{"key":"B79","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jgg.2020.03.003","article-title":"Severe cases of BCGosis-susceptible primary immunodeficiency diseases identified by next-generation sequencing: implications for adjustment of BCG vaccination timing in China","volume":"47","author":"Liu","year":"2020","journal-title":"J Genet Genomics"},{"key":"B80","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s10875-020-00865-9","article-title":"Infections in infants with SCID: isolation, infection screening, and prophylaxis in PIDTC centers","volume":"41","author":"Dorsey","year":"2021","journal-title":"J Clin Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10875-020-00892-6","article-title":"Bacillus calmette-guerin (BCG) vaccine-associated complications in immunodeficient patients following stem cell transplantation","volume":"41","author":"NaserEddin","year":"2021","journal-title":"J Clin Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.iac.2018.08.008","article-title":"Early-Onset inflammatory bowel disease","volume":"39","author":"Kelsen","year":"2019","journal-title":"Immunol Allergy Clin North Am"},{"key":"B83","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/ibd\/izz259","article-title":"Very early onset inflammatory bowel disease: a clinical approach with a focus on the role of genetics and underlying immune deficiencies","volume":"26","author":"Ouahed","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"B84","doi-asserted-by":"publisher","first-page":"675186","DOI":"10.3389\/fimmu.2021.675186","article-title":"The growing need to understand very early onset inflammatory bowel disease","volume":"12","author":"Zheng","year":"2021","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","article-title":"Classification criteria for autoinflammatory recurrent fevers","volume":"78","author":"Gattorno","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B86","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.autrev.2012.07.028","article-title":"Blau syndrome, clinical and genetic aspects","volume":"12","author":"Sfriso","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B87","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's Disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"B88","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1546-0096-12-33","article-title":"Blau syndrome, the prototypic auto-inflammatory granulomatous disease","volume":"12","author":"Wouters","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/children8020117","article-title":"NOD2 Mutation-Associated case with blau syndrome triggered by BCG vaccination","volume":"8","author":"Arakawa","year":"2021","journal-title":"Children (Basel)"},{"key":"B90","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11926-018-0749-x","article-title":"An update on autoinflammatory diseases: relopathies","volume":"20","author":"Steiner","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"B91","doi-asserted-by":"publisher","first-page":"895765","DOI":"10.3389\/fimmu.2022.895765","article-title":"Potential benefits of TNF targeting therapy in blau syndrome, a NOD2-associated systemic autoinflammatory granulomatosis","volume":"13","author":"Matsuda","year":"2022","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jaci.2020.08.017","article-title":"Monogenic autoinflammatory disorders: conceptual overview, phenotype, and clinical approach","volume":"146","author":"Nigrovic","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10875-015-0177-x","article-title":"PLAID: a syndrome of Complex patterns of disease and unique phenotypes","volume":"35","author":"Milner","year":"2015","journal-title":"J Clin Immunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1074-7613(00)00005-4","article-title":"Phospholipase Cgamma2 is essential in the functions of B cell and several fc receptors","volume":"13","author":"Wang","year":"2000","journal-title":"Immunity"},{"key":"B95","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1056\/NEJMoa1102140","article-title":"Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions","volume":"366","author":"Ombrello","year":"2012","journal-title":"N Engl J Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/pde.13972","article-title":"PLAID Syndrome: characteristic presentation and a novel therapeutic option","volume":"37","author":"Shea","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/intimm\/dxy021","article-title":"Using genes to triangulate the pathophysiology of granulomatous autoinflammatory disease: nOD2, PLCG2 and LACC1","volume":"30","author":"Szymanski","year":"2018","journal-title":"Int Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1001\/jamadermatol.2014.5641","article-title":"Distinct cutaneous manifestations and cold-induced leukocyte activation associated with PLCG2 mutations","volume":"151","author":"Aderibigbe","year":"2015","journal-title":"JAMA Dermatol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"O656","DOI":"10.1111\/1469-0691.12573","article-title":"Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency","volume":"20","author":"Bodemer","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"B100","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s10875-015-0207-8","article-title":"Late onset hypomorphic RAG2 deficiency presentation with fatal vaccine-strain VZV infection","volume":"35","author":"Dutmer","year":"2015","journal-title":"J Clin Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1001\/jamadermatol.2022.0828","article-title":"Association of persistent Rubella virus with idiopathic skin granulomas in clinically immunocompetent adults","volume":"158","author":"Wanat","year":"2022","journal-title":"JAMA Dermatol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"5849","DOI":"10.1128\/jvi.67.10.5849-5858.1993","article-title":"Rubella virus-specific cytotoxic T-lymphocyte responses: identification of the capsid as a target of major histocompatibility complex class I-restricted lysis and definition of two epitopes","volume":"67","author":"Lovett","year":"1993","journal-title":"J Virol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.coi.2011.05.005","article-title":"The narrowing of the CD8 T cell repertoire in old age","volume":"23","author":"Blackman","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"B104","first-page":"185","article-title":"Coccidioidomycosis: epidemiology","volume":"5","author":"Brown","year":"2013","journal-title":"Clin Epidemiol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3201\/eid1811.120752","article-title":"Coccidioidomycosis-associated deaths, United States, 1990-2008","volume":"18","author":"Huang","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"B106","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"Infectious diseases society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B107","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3201\/eid2302.160505","article-title":"Risk factors for disseminated coccidioidomycosis, United States","volume":"23","author":"Odio","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"B108","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1093\/mmy\/myy146","article-title":"A review of innate and adaptive immunity to coccidioidomycosis","volume":"57","author":"Hung","year":"2019","journal-title":"Med Mycol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4049\/immunohorizons.2200007","article-title":"Mouse model of a human STAT4 point mutation that predisposes to disseminated coccidiomycosis","volume":"6","author":"Powell","year":"2022","journal-title":"Immunohorizons"},{"key":"B110","doi-asserted-by":"publisher","first-page":"ofac403","DOI":"10.1093\/ofid\/ofac403","article-title":"Seronegative mediastinal coccidioidomycosis as a novel presentation of CTPS1 combined immunodeficiency","volume":"9","author":"Krase","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109135","article-title":"Prevalence of coccidioidomycosis in primary immunodeficiency: data from the USIDNET registry","author":"Krase","year":"2022","journal-title":"Clin Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/bjd.14295","article-title":"Chronic interstitial granulomatous dermatitis in coccidioidomycosis","volume":"174","author":"Mangold","year":"2016","journal-title":"Br J Dermatol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s40121-022-00606-y","article-title":"Coccidioidomycosis: a contemporary review","volume":"11","author":"Crum","year":"2022","journal-title":"Infect Dis Ther"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00296-019-04307-7","article-title":"Management of asymptomatic coccidioidomycosis in patients with rheumatic diseases","volume":"39","author":"Bilal","year":"2019","journal-title":"Rheumatol Int"},{"key":"B115","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.jaip.2021.10.073","article-title":"Respiratory infections in patients with primary immunodeficiency","volume":"10","author":"Lehman","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B116","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1165\/rcmb.2015-0212OC","article-title":"Molecular analysis of sarcoidosis granulomas reveals antimicrobial targets","volume":"55","author":"Rotsinger","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B117","doi-asserted-by":"crossref","first-page":"e0167471","DOI":"10.1371\/journal.pone.0167471","article-title":"Differential cytokine gene expression in granulomas from lungs and lymph nodes of cattle experimentally infected with aerosolized Mycobacterium bovis","volume":"11","author":"Palmer","year":"2016","journal-title":"PLoS One"},{"key":"B118","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/pai.12527","article-title":"Chronic granulomatous disease: clinical, molecular, and therapeutic aspects","volume":"27","author":"Chiriaco","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.antiviral.2017.09.019","article-title":"Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency","volume":"147","author":"Perelygina","year":"2017","journal-title":"Antiviral Res"},{"key":"B120","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10875-018-0581-0","article-title":"Rubella virus-associated cutaneous granulomatous disease: a unique complication in immune-deficient patients, not limited to DNA repair disorders","volume":"39","author":"Buchbinder","year":"2019","journal-title":"J Clin Immunol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.3389\/fimmu.2019.02265","article-title":"Metabolic programming of macrophages: implications in the pathogenesis of granulomatous disease","volume":"10","author":"Wilson","year":"2019","journal-title":"Front Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3390\/ani11061501","article-title":"Stages of granulomatous response against histozoic metazoan parasites in mullets (osteichthyes: mugilidae)","volume":"11","author":"Polinas","year":"2021","journal-title":"Animals (Basel)"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf3861","article-title":"PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques","volume":"6","author":"Kauffman","year":"2021","journal-title":"Sci Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210469","article-title":"Eosinophils are part of the granulocyte response in tuberculosis and promote host resistance in mice","volume":"218","author":"Bohrer","year":"2021","journal-title":"J Exp Med"},{"key":"B125","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1182\/blood-2017-12-820985","article-title":"Hypomorphic Rag1 mutations alter the preimmune repertoire at early stages of lymphoid development","volume":"132","author":"Ott de Bruin","year":"2018","journal-title":"Blood"},{"key":"B126","article-title":"Developing a Rag1-mutant murine model of Rubella vaccine-associated granulomatous inflammation","volume-title":"JOURNAL OF CLINICAL IMMUNOLOGY","author":"Sacco","year":"2021"},{"key":"B127","doi-asserted-by":"publisher","first-page":"790488","DOI":"10.3389\/fcimb.2021.790488","article-title":"Vaccine protection of mice with primary immunodeficiencies against disseminated coccidioidomycosis","volume":"11","author":"Powell","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.3389\/fimmu.2020.01719","article-title":"Current sarcoidosis models and the importance of focusing on the granuloma","volume":"11","author":"Locke","year":"2020","journal-title":"Front Immunol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1110115\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T07:28:18Z","timestamp":1676878098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1110115\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":128,"alternative-id":["10.3389\/fped.2023.1110115"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1110115","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]},"article-number":"1110115"}}